Descriptive statistics of driver characteristics. حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

Experimental scenario design. حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

Fixed effects of driving behavior stability. حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

Factors influencing cognitive response. حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

Speed variation at signal intersections (Time). حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

Selection of covariance types. حسب Yang Li (7082)

"…And older drivers slowed down and turned earlier at signal-controlled intersections. From a spatial perspective, older drivers experienced a decrease in speed before entering the two intersections, followed by a sustained increase in speed and steering wheel cornerings. …"

NADC30-like PRRSV activates the FAK-PI3K-AKT pathway through integrin <i>αV.</i> حسب Chunlin Li (180545)

Fig 2 - حسب Kieran L. Quinn (18127273)

Cataract induction does not affect hunting behaviour in optimal light conditions (left panels) but causes impairments in challenging light environments (right panels). حسب Amartya T. Mitra (14043115)

"…Similarly, under bright and UV light, we did not detect differences in hunting success (E,G; <i>n</i>_{<i>control</i>} = 12, <i>n</i>_{<i>lens3RNAi </i>}= 23, <i>p</i>_horizontal = 0.28, <i>p</i>_vertical = 0.23), but observed a weak (nonsignificant) decrease in the hunting success of treatment individuals under dim white light (F,H; <i>n</i>_{<i>control</i>} = 13, <i>n</i>_{<i>lens3RNAi </i>}= 22, <i>p</i>_horizontal = 0.22, <i>p</i>_vertical = 0.42).…"

Dot gain curves for three types of paper at different screen frequency. حسب Xiaoli Liu (165371)

"…<p>(a) 133 lpi and (b) 175 lpi. Dot gain initially increases and then decreases with rising dot area percentage, showing the most significant expansion in the mid-tone range (approximately 40%–60%) across coated, offset, and newsprint papers.…"

Frequency distribution of depths of coverage (DP) and allele balances (AB). حسب Eileen Marie Hanna (9693992)

Subject characteristics. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Raw data. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Flow diagram. حسب Barbara Mayr (7065950)

"…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…"

Proteomic and Lipidomic Plasma Evaluations Reveal Biomarkers for Domoic Acid Toxicosis in California Sea Lions حسب Amie M. Solosky (20320255)

"…Domoic acid is a neurotoxin secreted by the marine diatom genus <i>Pseudo-nitzschia</i> during toxic algal bloom events. …"

Proteomic and Lipidomic Plasma Evaluations Reveal Biomarkers for Domoic Acid Toxicosis in California Sea Lions حسب Amie M. Solosky (20320255)

"…Domoic acid is a neurotoxin secreted by the marine diatom genus <i>Pseudo-nitzschia</i> during toxic algal bloom events. …"

Image 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"

Table 3_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"

Image 2_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"

Table 7_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"